Biotech Software Development Services

Folio3 Digital Health provides custom biotech software development services for biotech companies, pharmaceutical firms, and medical innovators. The company builds HIPAA and 21 CFR Part 11-compliant platforms — including Laboratory Information Management Systems (LIMS), Electronic Lab Notebooks (ELN), and Clinical Trial Management Systems (CTMS) — designed to streamline experiment tracking, automate sample management, and support real-time analysis of genomics, proteomics, and clinical trial data.

The service addresses a common challenge in the biotech sector: research and clinical data scattered across labs, devices, and systems that cannot be easily unified or analyzed. Folio3 builds platforms that use AI, cloud infrastructure, and data lakes to centralize research, clinical, and operational data, with audit-ready logs, digital signatures, and role-based access controls embedded throughout.

Custom Biotech Software Services

• Laboratory Information Management Systems (LIMS): Automates sample tracking, inventory control, and lab workflows; supports device interoperability; built to HIPAA, GxP, and 21 CFR Part 11 standards.
• Electronic Lab Notebooks (ELN): Streamlines experiment documentation, protocols, and result tracking; integrates with eCRF and ePRO for real-time data collection; fully cloud-based and compliance-ready.
• Clinical Trial Management Systems (CTMS): Manages study setup, site enrollment, and trial logistics in a single platform; built to FDA/EMA compliance requirements; connects with third-party solutions and legacy systems.
• Bioinformatics and Genomic Data Platforms: Analyzes sequencing data including NGS, RNA-seq, and proteomics; provides secure cloud pipelines for gene annotation and variant analysis; uses AI models for genomic interpretation.
• Regulatory Compliance Automation Tools: Tracks system changes with full audit logs and version control; provides real-time alerting and documentation to reduce regulatory overhead; scalable for enterprise-level deployments.
• AI/ML Models for Drug Discovery and Clinical Insight: Supports AI-driven data annotation and predictive simulations; stratifies patient populations for trial design; ingests real-time data from wearables and biosensors.
• Integration Middleware and Data Exchange Engines: Connects EHRs, lab devices, CRMs, and third-party applications; supports HL7, FHIR, and OMOP CDM standards for healthcare interoperability.
• Remote Monitoring and IoT Platforms: Transmits data with low latency to cloud or on-premises systems; sends secure alerts to care teams or research staff; built to FDA-grade cybersecurity protocols.
• Biotech Data Lakes and Analytics Dashboards: Enables unified search, reporting, and analytics across datasets; supports custom KPIs and data visualization; built with ISO and HIPAA compliance for data protection.

Platform Capabilities and Features

• Built-in regulatory intelligence: HIPAA, GxP, and 21 CFR Part 11 compliance embedded directly into workflows, logs, and user access layers.
• Lab-centric architecture: LIMS and ELN modules integrated with sample tracking, lab workflows, and automated experiment documentation.
• System interoperability: Real-time interoperability between devices, trial systems, and health data pipelines using HL7, FHIR, CDISC, and OMOP standards.
• AI-driven research acceleration: Automated insights, anomaly detection, and predictive modeling to support research productivity.
• Scalable cloud-first frameworks: Elastic cloud infrastructure supporting AI/ML workloads, remote access, and advanced analytics.

Business Impact Areas

• Faster regulatory approval timelines: Built-in regulatory tools and automated validation workflows reduce approval cycle time.
• Accelerated time-to-clinic: Automated trial processes and integrated clinical tools shorten launch timelines.
• Improved R&D ROI: Predictive models reduce failed lab experiments; data-driven platforms support better research returns.
• Lower total cost of ownership: Future-ready software architecture reduces rework and maintenance costs.
• Reduced compliance risk: Audit-ready logs and HIPAA-secure features protect sensitive data and support regulatory compliance.

Integration Support

• EHR and EMR systems: Connects biotech platforms with electronic health records for clinical trial data sharing, patient recruitment, and real-time health record syncing.
• Laboratory instruments and IoT devices: Enables real-time lab data capture by connecting IoT-enabled instruments with custom dashboards and analytics pipelines.
• CRM platforms: Integrates with CRM systems such as Salesforce Health Cloud to track investigator communication, manage trials, and support sponsor-CRO collaboration.
• Regulatory and compliance frameworks: Supports HL7, FHIR, and CDISC standards for standardized data exchange, trial reporting, and regulatory submissions.

Development Framework

1. Strategy Alignment: Define biotech research goals, user requirements, and compliance needs to align the product roadmap.
2. Technical Blueprinting: Map FDA, EMA, and HIPAA guidelines to plan features, architecture, and integrations.
3. UI/UX Prototyping: Design workflows for scientists and clinicians and plan scalable, integration-ready system architecture.
4. Agile Development: Build HIPAA-ready software modules by deploying features in validated, iterative releases.
5. Data Integrity Testing: Validate the system using real biotech datasets, run audits, and test for security vulnerabilities.
6. Post-Launch Support: Monitor and optimize performance to maintain uptime, compliance, and ongoing enhancements.

Technology Stack

• Languages and frameworks: Python, Django, FastAPI, Node.js, NestJS, Vue.js, Angular, React, .NET Core, Flutter, Swift, Ruby on Rails.
• AI and big data: TensorFlow, PyTorch, Scikit-Learn, Apache Spark, Apache Kafka, Apache Hadoop.
• Healthcare interoperability: HL7, FHIR, DICOM, CDA, EPIC, Cerner.
• DevOps: Docker, Kubernetes, Jenkins, Terraform, Ansible, GitLab CI/CD.
• Cloud and security: AWS, Microsoft Azure, Google Cloud, Azure IAM, MFA, HIPAA-compliant infrastructure.

Folio3 Digital Health reports 19 or more years of experience in digital health software development. Custom biotech software MVPs are typically priced between USD $20,000 and $200,000 or more, with development timelines ranging from 3 to 9 months depending on complexity, integrations, and compliance requirements. The company offers phased delivery to support incremental value realization.